China Resources Boya Bio-pharmaceutical Group Co (SZSE:300294) Days Sales Outstanding : 88.56 (As of Mar. 2025)

View and export this data going back to 2012. Start your Free Trial

What is China Resources Boya Bio-pharmaceutical Group Co Days Sales Outstanding?

China Resources Boya Bio-pharmaceutical Group Co's average Accounts Receivable for the three months ended in Mar. 2025 was ¥520 Mil. China Resources Boya Bio-pharmaceutical Group Co's Revenue for the three months ended in Mar. 2025 was ¥536 Mil. Hence, China Resources Boya Bio-pharmaceutical Group Co's Days Sales Outstanding for the three months ended in Mar. 2025 was 88.56.

The historical rank and industry rank for China Resources Boya Bio-pharmaceutical Group Co's Days Sales Outstanding or its related term are showing as below:

SZSE:300294' s Days Sales Outstanding Range Over the Past 10 Years
Min: 38.71 Med: 60.22 Max: 75.86
Current: 75.86

During the past 13 years, China Resources Boya Bio-pharmaceutical Group Co's highest Days Sales Outstanding was 75.86. The lowest was 38.71. And the median was 60.22.

SZSE:300294's Days Sales Outstanding is ranked worse than
54.44% of 845 companies
in the Biotechnology industry
Industry Median: 69.43 vs SZSE:300294: 75.86

China Resources Boya Bio-pharmaceutical Group Co's Days Sales Outstanding increased from Mar. 2024 (45.85) to Mar. 2025 (88.56).

China Resources Boya Bio-pharmaceutical Group Co Days Sales Outstanding Historical Data

The historical data trend for China Resources Boya Bio-pharmaceutical Group Co's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

China Resources Boya Bio-pharmaceutical Group Co Days Sales Outstanding Chart

China Resources Boya Bio-pharmaceutical Group Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Days Sales Outstanding

Get a 7-Day Free Trial

73.96

61.76

59.99

46.21

69.25

China Resources Boya Bio-pharmaceutical Group Co Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Days Sales Outstanding	Get a 7-Day Free Trial															45.85	57.17	80.02	69.08	88.56

Competitive Comparison of China Resources Boya Bio-pharmaceutical Group Co's Days Sales Outstanding

For the Biotechnology subindustry, China Resources Boya Bio-pharmaceutical Group Co's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

China Resources Boya Bio-pharmaceutical Group Co's Days Sales Outstanding Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, China Resources Boya Bio-pharmaceutical Group Co's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where China Resources Boya Bio-pharmaceutical Group Co's Days Sales Outstanding falls into.

Save Embed

;

Save Embed

;

China Resources Boya Bio-pharmaceutical Group Co Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

China Resources Boya Bio-pharmaceutical Group Co's Days Sales Outstanding for the fiscal year that ended in Dec. 2024 is calculated as

	Days Sales Outstanding (A: Dec. 2024 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2023 )	+	Accounts Receivable (A: Dec. 2024 ))	/	count )	/	Revenue (A: Dec. 2024 )	*	Days in Period
=	( (209.837	+	448.471)	/	2 )	/	1734.904	*	365
=	329.154					/	1734.904	*	365
=	69.25

China Resources Boya Bio-pharmaceutical Group Co's Days Sales Outstanding for the quarter that ended in Mar. 2025 is calculated as:

	Days Sales Outstanding (Q: Mar. 2025 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2024 )	+	Accounts Receivable (A: Mar. 2025 ))	/	count )	/	Revenue (A: Mar. 2025 )	*	Days in Period
=	( (448.471	+	591.734)	/	2 )	/	535.877	*	365 / 4
=	520.1025					/	535.877	*	365 / 4
=	88.56

China Resources Boya Bio-pharmaceutical Group Co (SZSE:300294) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

China Resources Boya Bio-pharmaceutical Group Co Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of China Resources Boya Bio-pharmaceutical Group Co's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

China Resources Boya Bio-pharmaceutical Group Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » China Resources Boya Bio-pharmaceutical Group Co Ltd (SZSE:300294) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

N/A

Address

Number 333, Huiquan Road, High-tech Industrial Park, Jiangxi Province, Fuzhou, CHN, 344000

Website

https://www.china-boya.com

China Resources Boya Bio-pharmaceutical Group Co Ltd is a China-based medical industry group that integrates biochemical drugs, chemical drugs, and active pharmaceutical ingredients. It is engaged in the provision of medical and health products and services. The product categories of the company include blood products, biochemical drugs, chemical medicines and others. Some of the company's blood products include human albumin, rabies immunoglobulin, intravenous human immunoglobulin and human fibrinogen.

Executives

Liang Xiao Ming	Directors, executives
Li Shou Sun	Executives
Zhang Shi Fang	Executives
Tu Yan Shi	Directors, executives
Chen Bing	Executives
Liao Xin Xi	Directors, executives
Fan Yi Qin	Secretary, Director
Jiang Guo Liang	Supervisors
Xu Jian Xin	Director
Duan Hong Zhuan	Executives
Chen Hai Yan	Executives
Hong Da Cheng	Director

China Resources Boya Bio-pharmaceutical Group Co Headlines

No Headlines